$东阳光长江药业(0_老虎社区_美港股上老虎

$东阳光长江药业(01558)$ 东阳光药是少数以自主研发驱动的中国制药公司之一，公司将自主原研创新确定为核心战略。截至2024年6月30日，东阳光药申请的发明专利总量为2403项，已获得授权的境内外发明专利合计达到1351项。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":445184665620512,"tweetId":"445184665620512","gmtCreate":1749709045399,"gmtModify":1749709046825,"author":{"id":4107239966895660,"idStr":"4107239966895660","authorId":4107239966895660,"authorIdStr":"4107239966895660","name":"向阳花之光","avatar":"https://static.tigerbbs.com/e322d38c22fa6cc88f0c102424c4a365","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01558\">$东阳光长江药业(01558)$ &nbsp;</a>东阳光药是少数以自主研发驱动的中国制药公司之一，公司将自主原研创新确定为核心战略。截至2024年6月30日，东阳光药申请的发明专利总量为2403项，已获得授权的境内外发明专利合计达到1351项。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01558\">$东阳光长江药业(01558)$ &nbsp;</a>东阳光药是少数以自主研发驱动的中国制药公司之一，公司将自主原研创新确定为核心战略。截至2024年6月30日，东阳光药申请的发明专利总量为2403项，已获得授权的境内外发明专利合计达到1351项。</p></body></html>","text":"$东阳光长江药业(01558)$ 东阳光药是少数以自主研发驱动的中国制药公司之一，公司将自主原研创新确定为核心战略。截至2024年6月30日，东阳光药申请的发明专利总量为2403项，已获得授权的境内外发明专利合计达到1351项。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/445184665620512","repostId":0,"isVote":1,"tweetType":1,"viewCount":308,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01558"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":197,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}